Device / Technology News

RSS

New study could help reduce radiation exposure during cardiac CT scans

A new study at The University of Texas at Arlington could help substantially reduce the amount of radiation heart patients receive during imaging procedures without sacrificing diagnostic accuracy.

15 Oct 2026

New paper urges adoption of green AI in healthcare

AI is already widely used in hospitals and medical research. Can a new way of thinking unleash the technology’s green credentials?

15 Oct 2026

New AI project models human behavior to track epidemic spread

A consortium led by the University de Zaragoza, with the participation of Universidad Carlos III de Madrid (UC3M), has been selected in the 2026 Health Research Call by the "la Caixa" Foundation—one of the most competitive biomedical research funding calls in Spain and Portugal.

15 Oct 2026

INmune Bio Inc. and Quantum Computing Inc. partner to apply quantum optimization and AI to advance Alzheimer’s drug research and explore new applications for XPro

INmune Bio Inc. and Quantum Computing Inc. today announced a collaboration to apply quantum computing, artificial intelligence (AI) and data analytics to identify new potential applications for XPro (XPro1595), INmune Bio's investigational treatment for Alzheimer's disease and other disease conditions.

From INmune Bio 15 Oct 2026

AI detects daily stress by analyzing routine smartphone behaviors

Clues to stress can be hidden in everyday habits such as chatting, searching, and making payments on a smartphone.

14 Oct 2026

Bulk adverse event reporting may delay medical device safety warnings

Permitting medical device manufacturers to submit bulk summary reports of adverse events to the US Food and Drug Administration (FDA), rather than reporting individual cases, often fails to promptly detect potential safety signals, finds a study published by The BMJ today.

14 Oct 2026

Human accountability remains essential as healthcare adopts AI

With artificial intelligence making deep inroads into healthcare, two top doctors are urging physicians to embrace the technology but to remember that only humans can serve the best interest of individual patients.

14 Oct 2026

New project receives $2.3 million to develop a database and AI model to identify therapeutic peptides

A group of scientists led by Joseph Brown, assistant professor at the Leslie Dan Faculty of Pharmacy, has received $2.3 million USD in funding to develop a database and AI training model to identify peptides with therapeutic potential.

14 Oct 2026

Novel gene rejuvenation therapy preserves cell identity while reversing age

Every organ and tissue progressively loses function and integrity as it ages. In fact, researchers have identified "hallmarks of aging" that not only present specific processes impacted by age, but are also thought of as levers that, if successfully targeted, could help turn back the aging clock and result in tissue rejuvenation.

14 Oct 2026

Novel bioprinting technique successfully replicates mature human fat tissue

A research team has developed a support-bath bioprinting method that enables fragile, mature human adipocytes to be incorporated into geometrically defined three-dimensional (3D) constructs while retaining their viability, characteristic lipid-filled morphology, and metabolic activity.

14 Oct 2026

New eye model guides lighting designs for aging adults

Researchers have developed a new computational model that accounts for the effects of aging on our eyes' ability to discriminate color.

14 Oct 2026

Seragy launches with €12 million financing to advance quantitative biomarkers for neurodegenerative diseases

seragy holding GmbH (formerly Prosperodes GmbH), a biomarker strategy company focused on neurodegenerative diseases and other proteopathies, has secured €12 million in funding to accelerate the development of its SeRAS® platform (Seed Replication, Analysis and Subtyping) and expand its laboratory and analytical capabilities. The financing is backed by Commerzbank, the Mittelständische Beteiligungsgesellschaft (MBG), and the State of Lower Saxony.

14 Oct 2026

Chemists develop blueprint for designing powerful fluorescent materials for better disease detection

Chemists at the University of Bath have discovered how tiny molecular changes can transform the color and brightness of fluorescent probes based on the blue molecule azulene, paving the way for more powerful imaging tools for detecting diseases such as Alzheimer's, Parkinson’s and cancer.

14 Oct 2026

Enhancing CRISPR analysis with INTEGRA automation

Biotechnology company QUiCKR Bio is using liquid handling solutions from INTEGRA Biosciences to run its CRISPR edit confirmation assays.

From INTEGRA Biosciences 14 Oct 2026

Researchers improve CRISPR technology for detecting HIV and other RNA viruses

Scientists have long used a powerful gene-editing tool called CRISPR to make precise changes to DNA. But a different version of the technology, known as Cas13a, targets RNA, the genetic material found in viruses such as HIV.

13 Oct 2026

Charity funds Aston University research into childhood cancer MRI

Aston University's Dr Jan Novak has accepted funding of £45,000 from cancer charity Help Harry Help Others (HHHO) to support a PhD student to research new ways of using MRI scans of children with cancer to better inform their doctors and improve treatment.

13 Oct 2026

Consumer smartwatch helps identify adults with severe sleep apnea

New research suggests that a consumer smartwatch can help identify adults with moderate-to-severe obstructive sleep apnea, offering a way to screen for a common sleep disorder that often goes undiagnosed.

13 Oct 2026

Hybrid AI architecture improves seizure prediction using EEG signals

Epilepsy affects about 50 million people worldwide and can seriously affect patients' quality of life. Electroencephalography (EEG), which records the brain's electrical activity in real time, plays an important role in epilepsy diagnosis and monitoring.

13 Oct 2026

New AI tool distinguishes Ewing sarcoma with high accuracy

A team from the Universitat Politècnica de València (UPV) and the University of Valencia (UV) has developed and validated an artificial intelligence (AI) system capable of distinguishing Ewing sarcoma from other morphologically similar tumours with high accuracy.

13 Oct 2026

Light-activated cotton fabric reduces harmful microorganisms in hospital rooms

A team from the Alcoy campus of the Universitat Politècnica de València (UPV), the Research Institute for Chemical Technology (ITQ, CSIC-UPV), the Research Institute for Mediterranean Agroforestry (IAM UPV) and the Joint Research Unit between the UPV and the Health Research Institute at La Fe Hospital in Valencia (UPV-IISLaFe) has developed a new self-disinfecting cotton fabric capable of eliminating bacteria, fungi and viruses in hospital settings using visible light.

13 Oct 2026